Literature DB >> 11408165

Molecular cloning, expression and characterization of the first three genes in the mevalonate-independent isoprenoid pathway in Streptomyces coelicolor.

D E Cane1, C Chow, A Lillo, I Kang.   

Abstract

The mevalonate-independent biosynthetic pathway to isopentenyl diphosphate and dimethylallyl diphosphate, the universal precursors to the isoprenoids, operates in eubacteria, including Escherichia coli, in algae, and in the plastids of higher plants. A search of the Sanger Centre Streptomyces coelicolor genome database revealed open reading frames with ca. 40--50% identity at the deduced amino acid level to the first three E. coli enzymes of this pathway, corresponding to deoxyxylulose phosphate synthase, deoxyxylulose phosphate reductoisomerase and 2-C-methyl erythritol 4-phosphate cytidylyltransferase. The S. coelicolor genes have been cloned and expressed in E. coli, and the recombinant proteins characterized physically and kinetically. The presence of the corresponding enzyme activities in extracts of S. coelicolor CH999 further supports the operation of the mevalonate-independent pathway in this organism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408165     DOI: 10.1016/s0968-0896(01)00050-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by Dxs.

Authors:  Amanda C Brown; Matthias Eberl; Dean C Crick; Hassan Jomaa; Tanya Parish
Journal:  J Bacteriol       Date:  2010-02-19       Impact factor: 3.490

2.  1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.

Authors:  Rakesh K Dhiman; Merrill L Schaeffer; Ann Marie Bailey; Charles A Testa; Hataichanok Scherman; Dean C Crick
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 3.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

Review 4.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

Review 5.  Knowns and unknowns of membrane lipid synthesis in streptomycetes.

Authors:  Mario Sandoval-Calderón; Ziqiang Guan; Christian Sohlenkamp
Journal:  Biochimie       Date:  2017-05-15       Impact factor: 4.079

6.  Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis: Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes.

Authors:  Jérôme de Ruyck; Johan Wouters; C Dale Poulter
Journal:  Curr Enzym Inhib       Date:  2011-07

7.  1-Deoxy-D-xylulose 5-phosphate synthase catalyzes a novel random sequential mechanism.

Authors:  Leighanne A Brammer; Jessica M Smith; Herschel Wade; Caren Freel Meyers
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

8.  Homology modeling of Mycobacterium tuberculosis 2C-methyl-D-erythritol-4-phosphate cytidylyltransferase, the third enzyme in the MEP pathway for isoprenoid biosynthesis.

Authors:  Cristian Obiol-Pardo; Alex Cordero; Jaime Rubio-Martinez; Santiago Imperial
Journal:  J Mol Model       Date:  2009-11-15       Impact factor: 1.810

9.  A structural and functional study on the 2-C-methyl-d-erythritol-4-phosphate cytidyltransferase (IspD) from Bacillus subtilis.

Authors:  Yun Jin; Zhongchuan Liu; Yanjie Li; Weifeng Liu; Yong Tao; Ganggang Wang
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Synthesis and Kinetic evaluation of an azido analogue of methylerythritol phosphate: a Novel Inhibitor of E. coli YgbP/IspD.

Authors:  Zoljargal Baatarkhuu; Philippe Chaignon; Franck Borel; Jean-Luc Ferrer; Alain Wagner; Myriam Seemann
Journal:  Sci Rep       Date:  2018-12-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.